Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to -$6.1 million.

  • Cresco Labs' Cash from Investing Activities rose 231.3% to -$6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.8 million, marking a year-over-year increase of 5523.96%. This contributed to the annual value of -$25.2 million for FY2024, which is 4341.37% up from last year.
  • Per Cresco Labs' latest filing, its Cash from Investing Activities stood at -$6.1 million for Q3 2025, which was up 231.3% from -$3.0 million recorded in Q4 2024.
  • Cresco Labs' Cash from Investing Activities' 5-year high stood at $23.5 million during Q3 2022, with a 5-year trough of -$64.1 million in Q4 2021.
  • Its 5-year average for Cash from Investing Activities is -$16.2 million, with a median of -$12.5 million in 2022.
  • As far as peak fluctuations go, Cresco Labs' Cash from Investing Activities crashed by 58177.18% in 2021, and later skyrocketed by 15404.96% in 2022.
  • Quarter analysis of 5 years shows Cresco Labs' Cash from Investing Activities stood at -$64.1 million in 2021, then surged by 80.57% to -$12.5 million in 2022, then surged by 120.95% to $2.6 million in 2023, then tumbled by 215.48% to -$3.0 million in 2024, then plummeted by 103.25% to -$6.1 million in 2025.
  • Its Cash from Investing Activities stands at -$6.1 million for Q3 2025, versus -$3.0 million for Q4 2024 and -$6.3 million for Q3 2024.